We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$138M
AUM Growth
-$9.31M
Cap. Flow
-$9.71M
Cap. Flow %
-7.03%
Top 10 Hldgs %
24.49%
Holding
191
New
28
Increased
25
Reduced
77
Closed
34

Top Buys

Rank Stock Value
1
TSN icon
Tyson Foods
TSN
+$935K
2
MET icon
MetLife
MET
+$903K
3
FOX icon
Fox Class B
FOX
+$867K
4
CAG icon
Conagra Brands
CAG
+$770K
5
ELAN icon
Elanco Animal Health
ELAN
+$663K

Sector Composition

Rank Sector Weight
1 Healthcare 19.04%
2 Consumer Staples 15.56%
3 Industrials 14.75%
4 Technology 13.52%
5 Financials 12.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLB icon
126
SLB Ltd
SLB
$79.5B
$300K 0.22%
8,774
-100
-1% -$3.65K
TMUS icon
127
T-Mobile US
TMUS
$193B
$282K 0.2%
3,575
-3,875
-52% -$304K
MRVL icon
128
Marvell Technology
MRVL
$209B
$280K 0.2%
+11,200
New +$281K
VEEV icon
129
Veeva Systems
VEEV
$43.2B
$275K 0.2%
+1,800
New +$289K
RTN
130
DELISTED
Raytheon Company
RTN
$275K 0.2%
1,400
-350
-20% -$64.8K
GE icon
131
GE Aerospace
GE
$324B
$272K 0.2%
6,097
-1,362
-18% -$64K
KNX icon
132
Knight Transportation
KNX
$10.8B
$272K 0.2%
+7,500
New +$261K
MSCI icon
133
MSCI
MSCI
$39.9B
$267K 0.19%
+1,225
New +$284K
AZN icon
134
AstraZeneca
AZN
$255B
$263K 0.19%
2,954
AAL icon
135
American Airlines Group
AAL
$8.51B
$259K 0.19%
9,612
-1,725
-15% -$50.5K
SPLK
136
DELISTED
Splunk Inc
SPLK
$259K 0.19%
+2,200
New +$275K
HSBC.PRA
137
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$255K 0.18%
9,700
H icon
138
Hyatt Hotels
H
$15.2B
$249K 0.18%
+3,375
New +$255K
MAS icon
139
Masco
MAS
$13.6B
$248K 0.18%
+5,950
New +$239K
ORCL icon
140
Oracle
ORCL
$438B
$248K 0.18%
+4,500
New +$249K
SHW icon
141
Sherwin-Williams
SHW
$78.8B
$247K 0.18%
1,350
CDNS icon
142
Cadence Design Systems
CDNS
$76.8B
$230K 0.17%
+3,475
New +$244K
INTU icon
143
Intuit
INTU
$86.3B
$226K 0.16%
850
-50
-6% -$13.8K
ALL icon
144
Allstate
ALL
$65.1B
$217K 0.16%
2,000
FCX icon
145
Freeport-McMoran
FCX
$99.8B
$217K 0.16%
22,650
-4,850
-18% -$49.8K
SIVB
146
DELISTED
SVB Financial Group
SIVB
$214K 0.16%
1,025
XYL icon
147
Xylem
XYL
$25.4B
$207K 0.15%
2,600
CTXS
148
DELISTED
Citrix Systems Inc
CTXS
$200K 0.14%
+2,075
New +$198K
CTRA
149
DELISTED
Coterra Energy
CTRA
$188K 0.14%
10,700
-200
-2% -$3.83K
VIAV icon
150
Viavi Solutions
VIAV
$8.68B
$158K 0.11%
+11,250
New +$160K

Similar funds

New England Research & Management's Q3 2019 Portfolio in Review

As of Q3 2019, New England Research & Management held 191 positions worth $138M, down 6.3% from $147M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management withdrew a net $9.71M in Q3 2019, closing 34 positions and reducing 77 holdings. Its most notable exit was Amgen, an estimated $1.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, New England Research & Management opened a new position in Tyson Foods worth $948K.

  • New England Research & Management's largest Q3 2019 buy was Tyson Foods: 11,000 shares worth $948K.
  • New England Research & Management added most to Elanco Animal Health in Q3 2019, an estimated $663K increase.
  • New England Research & Management's biggest Q3 2019 reduction was Estee Lauder, cutting an estimated $1.41M.
  • New England Research & Management fully exited Amgen in Q3 2019, selling an estimated $1.8M.
  • New England Research & Management's ten largest holdings make up 24% of its $138M portfolio in Q3 2019.
  • New England Research & Management opened 28 new positions and closed 34 in Q3 2019.
  • New England Research & Management's portfolio value fell 6.3% quarter-over-quarter to $138M.

Based on New England Research & Management's 13F filing for Q3 2019, filed 4 Nov 2019.